D. Hacking and J. Hull, Respiratory syncytial virus -viral biology and the host response, J Infect, vol.45, pp.18-24, 2002.

P. L. Collins and B. S. Graham, Viral and host factors in human respiratory syncytial virus pathogenesis, J Virol, vol.82, pp.2040-55, 2008.

J. B. Domachowske and H. F. Rosenberg, Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment, Clin Microbiol Rev, vol.12, pp.298-309, 1999.

J. Chang and T. J. Braciale, Respiratory syncytial virus infection suppresses lung CD8 + T-cell effector activity and peripheral CD8

, + T-cell memory in the respiratory tract, Nat Med, vol.8, pp.54-60, 2002.

T. J. Braciale, Respiratory syncytial virus and T cells: interplay between the virus and the host adaptive immune system, Proc Am Thorac Soc, vol.2, pp.141-147, 2005.

P. A. Gonzalez, C. E. Prado, E. D. Leiva, L. J. Carreno, S. M. Bueno et al., Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells, Proc Natl Acad Sci U S A, vol.105, pp.14999-5004, 2008.

P. M. De-graaff, E. C. De-jong, T. M. Van-capel, M. E. Van-dijk, P. J. Roholl et al., Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells, J Immunol, vol.175, pp.5904-5915, 2005.

R. Chanock, B. Roizman, and R. Myers, Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA): isolation, properties and characterization, Am J Hyg, vol.66, pp.281-90, 1957.

D. V. Araya, T. S. Quiroz, H. E. Tobar, R. J. Lizana, C. P. Quezada et al., Deletion of a prophage-like element causes attenuation of Salmonella enterica serovar Enteritidis and promotes protective immunity, Vaccine, vol.28, pp.5458-66, 2010.

A. Z. Kapikian, R. H. Mitchell, R. M. Chanock, R. A. Shvedoff, and C. E. Stewart, An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine, Am J Epidemiol, vol.89, pp.405-426, 1969.

H. W. Kim, J. G. Canchola, C. D. Brandt, G. Pyles, R. M. Chanock et al., Respiratory syncytial virus disease in infants despite prior aministration of antigenic inactivated vaccine, Am J Epidemiol, vol.89, pp.422-456, 1969.

T. S. Quiroz, P. A. Nieto, H. E. Tobar, F. J. Salazar-echegarai, R. J. Lizana et al., Excision of an unstable pathogenicity island in Salmonella enterica serovar Enteritidis is induced during infection of phagocytic cells, PLoS ONE, vol.6, p.26031, 2011.

C. A. Santiviago, C. J. Blondel, C. P. Quezada, C. A. Silva, P. M. Tobar et al., Spontaneous excision of the Salmonella enterica serovar Enteritidis-specific defective prophage-like element phiSE14, J Bacteriol, vol.192, pp.2246-54, 2010.

N. Aaopcoidacofa, Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV, Pediatrics, vol.102, pp.1211-1217, 1998.

S. Johnson, C. Oliver, G. A. Prince, V. G. Hemming, D. S. Pfarr et al., Dvelopment of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus, J Infect Dis, vol.176, pp.1215-1239, 1997.

T. Group and . Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants, Pediatrics, vol.102, issue.3, pp.531-538, 1998.

A. Mej-ias, S. Bueno, A. M. Saavedra-lozano, J. Fonseca-aten, M. Hatfield et al., Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model, Antimicrob Agents Chemother, vol.48, pp.1811-1833, 2004.

A. Mej-ias, S. Bueno, M. F. Aten, B. Raynor, and E. Peromingo, Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency, Antimicrob Agents Chemother, vol.49, pp.4700-4707, 2005.

N. D. Embleton, C. Harkensee, and M. C. Mckean, Palivizumab for preterm infants. Is it worth it?, Arch Dis Child Fetal Neonatal Ed, vol.90, pp.286-295, 2005.

C. Harkensee, M. Brodlie, N. D. Embleton, and M. Mckean, Passive immunisation of preterm infants with palivizumab against RSV infection, J Infect, vol.52, pp.2-8, 2006.

J. Jans, M. Vissers, J. G. Heldens, M. I. De-jonge, O. Levy et al., Fcc receptors in respiratory syncytial virus infections: implications for innate immunity, Rev Med Virol, vol.24, pp.55-70, 2014.

D. Kruijsen, M. J. Bakkers, N. O. Van-uden, M. C. Viveen, T. C. Van-der-sluis et al., Serum antibodies critically affect virus-specific CD4

. +-/cd8,

, + T cell balance during respiratory syncytial virus infections, J Immunol, vol.185, pp.6489-98, 2010.

D. Kruijsen, H. K. Einarsdottir, M. A. Schijf, F. E. Coenjaerts, E. C. Van-der-schoot et al., Intranasal administration of antibody-bound respiratory syncytial virus particles efficiently primes virus-specific immune responses in mice, J Virol, vol.87, pp.7550-7557, 2013.

A. A. Herrada, F. J. Contreras, J. A. Tobar, R. Pacheco, and A. M. Kalergis, Immune complexinduced enhancement of bacterial antigen presentation requires Fcc receptor III expression on dendritic cells, Proc Natl Acad Sci U S A, vol.104, pp.13402-13409, 2007.

A. M. Kalergis, Modulation of T cell immunity by TCR/pMHC dwell time and activating/ inhibitory receptor pairs on the antigen-presenting cell, Curr Pharm Des, vol.9, pp.233-277, 2003.

J. A. Tobar, P. A. Gonzalez, and A. M. Kalergis, Salmonella escape from antigen presentation can be overcome by targeting bacteria to Fcc receptors on dendritic cells, J Immunol, vol.173, pp.4058-65, 2004.

V. C. Huber, J. M. Lynch, D. J. Bucher, J. Le, and D. W. Metzger, Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections, J Immunol, vol.166, pp.7381-7389, 2001.

K. Boonnak, B. M. Slike, and T. H. Burgess, Role of dendritic cells in antibody-dependent enhancement of dengue virus infection, J Virol, vol.82, pp.3939-51, 2008.

S. Qiao, Z. Jiang, X. Tian, R. Wang, G. Xing et al., Porcine FccRIIb mediates enhancement of porcine reproductive and respiratory syndrome virus (PRRSV) infection, PLoS ONE, vol.6, p.28721, 2011.

D. Wilflingseder, Z. Banki, E. Garcia, M. Pruenster, G. Pfister et al., IgG opsonization of HIV impedes provirus formation in and infection of dendritic cells and subsequent long-term transfer to T cells, J Immunol, vol.178, pp.7840-7848, 2007.

S. M. Bueno, P. A. Gonzalez, L. J. Carreno, J. A. Tobar, G. C. Mora et al., The capacity of Salmonella to survive inside dendritic cells and prevent antigen presentation to T cells is host specific, Immunology, vol.124, pp.522-555, 2008.

S. Amigorena and C. Bonnerot, Fc receptor signaling and trafficking: a connection for antigen processing, Immunol Rev, vol.172, pp.279-84, 1999.

J. V. Ravetch and S. Bolland, IgG Fc receptors, Annu Rev Immunol, vol.19, pp.275-90, 2001.

J. V. Ravetch, Fc receptors, Curr Opin Immunol, vol.9, pp.121-126, 1997.
URL : https://hal.archives-ouvertes.fr/hal-01996170

M. I. Iruretagoyena, C. A. Riedel, E. D. Leiva, M. A. Gutierrez, S. H. Jacobelli et al., Activating and inhibitory Fcc receptors can differentially modulate T cell-mediated autoimmunity, Eur J Immunol, vol.38, pp.2241-50, 2008.

J. Banchereau, F. Briere, C. Caux, J. Davoust, S. Lebecque et al., Immunobiology of dendritic cells, Annu Rev Immunol, vol.18, pp.767-811, 2000.

A. A. Itano and M. K. Jenkins, Antigen presentation to naive CD4 T cells in the lymph node

, Nat Immunol, vol.4, pp.733-742, 2003.

J. Arbiza, G. Taylor, J. A. Furze, J. Wyld, S. Whyte et al., Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus, J Gen Virol, vol.73, pp.2225-2259, 1992.

C. Bourgeois, J. B. Bour, L. S. Aho, and P. Pothier, Prophylactic administration of a complementarity-determining region derived from a neutralizing monoclonal antibody is effective against respiratory syncytial virus infection in BALB/c mice, J Virol, vol.72, pp.807-817, 1998.

C. Bourgeois, C. Corvaisier, J. B. Bour, E. Kohli, and P. Pothier, Use of synthetic peptides to locate neutralizing antigenic domains on the fusion protein of respiratory syncytial virus, J Gen Virol, vol.72, pp.1051-1059, 1991.

J. M. Robertson, P. E. Jensen, and B. D. Evavold, DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope, J Immunol, vol.164, pp.4706-4718, 2000.

R. S. G-omez, J. E. Mora, C. M. Cort-es, C. A. Riedel, M. Ferr-es et al., Respiratory syncytial virus detection in cells and clinical samples by using three new monoclonal antibodies, J Med Virol, pp.86-1256, 2014.

P. F. C-espedes, S. M. Bueno, R. Ba, R. S. Gomez, S. A. Riquelme et al., Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells, Proc Natl Acad Sci U S A, vol.111, pp.3214-3237, 2014.

L. Nou?-en, C. Munir, S. Losq, S. Winter, C. C. Mccarty et al., Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3, Virology, vol.385, pp.169-82, 2009.

M. S. Boukhvalova, G. A. Prince, and J. C. Blanco, Respiratory syncytial virus infects and abortively replicates in the lungs in spite of preexisting immunity, J Virol, vol.81, pp.9443-50, 2007.

Z. B-anki, L. Kacani, B. M?-ullauer, D. Wilflingseder, G. Obermoser et al., Cross-linking of CD32 induces maturation of human monocyte-derived dendritic cells via NF-jB signaling pathway, J Immunol, vol.170, pp.3963-70, 2003.

C. Sedlik, D. Orbach, P. Veron, E. Schweighoffer, F. Colucci et al., A critical role for Syk protein tyrosine kinase in Fc receptor-mediated antigen presentation and induction of dendritic cell maturation, J Immunol, vol.170, pp.846-52, 2003.

D. N. Forthal and C. Moog, Fc receptor-mediated antiviral antibodies, Curr Opin HIV AIDS, vol.4, pp.388-93, 2009.

M. Beyer, H. Bartz, K. Horner, S. Doths, C. Koerner-rettberg et al., Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection, J Allergy Clin Immunol, vol.113, pp.127-160, 2004.

A. Guerrero-plata, D. Kolli, C. Hong, A. Casola, and R. P. Garofalo, Subversion of pulmonary dendritic cell function by paramyxovirus infections, J Immunol, vol.182, pp.3072-83, 2009.

W. L. Hazenbos, J. E. Gessner, F. M. Hofhuis, H. Kuipers, D. Meyer et al., Impaired IgG-dependent anaphylaxis and Arthus reaction in Fcc RIII (CD16) deficient mice, Immunity, vol.5, pp.181-189, 1996.

K. R. Chan, S. L. Zhang, H. C. Tan, Y. K. Chan, A. Chow et al., Ligation of Fcc receptor IIB inhibits antibody-dependent enhancement of dengue virus infection, Proc Natl Acad Sci U S A, vol.108, pp.12479-84, 2011.

A. Regnault, D. Lankar, V. Lacabanne, A. Rodriguez, C. Th-ery et al., Fcc receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization, J Exp Med, vol.189, pp.371-80, 1999.

J. S. Mclellan, M. Chen, J. S. Chang, Y. Yang, A. Kim et al., Structure of a major antigenic site on the respiratory syncytial virus fusion glycoprotein in complex with neutralizing antibody 101F, J Virol, vol.84, pp.12236-12280, 2010.

G. R. Lounsbach, C. Bourgeois, W. H. West, J. W. Robinson, M. J. Carter et al., Binding of neutralizing monoclonal antibodies to regions of the fusion protein of ª, J Gen Virol, vol.147, pp.2559-65, 1993.

W. H. West, G. R. Lounsbach, C. Bourgeois, J. W. Robinson, M. J. Carter et al., Biological activity, binding site and affinity of monoclonal antibodies to the fusion protein of respiratory syncytial virus, J Gen Virol, vol.75, pp.2813-2822, 1994.

J. A. Beeler and K. Van-wyke-coelingh, Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function, J Virol, vol.63, pp.2941-50, 1989.

B. Geevarghese and E. A. Simoes, Antibodies for prevention and treatment of respiratory syncytial virus infections in children, Antivir Ther, vol.17, pp.201-212, 2012.

L. J. Ioannidis, E. E. Verity, S. Crawford, S. P. Rockman, and L. E. Brown, Abortive replication of influenza virus in mouse dendritic cells, J Virol, vol.86, pp.5922-5927, 2012.

C. B. Lopez, A. Fernandez-sesma, S. M. Czelusniak, J. L. Schulman, and T. M. Moran, A mouse model for immunization with ex vivo virus-infected dendritic cells, Cell Immunol, vol.206, pp.107-122, 2000.

S. B. Spring, B. Roizman, and J. Schwartz, Herpes simplex virus products in productive and abortive infection. II. Electron microscopic and immunological evidence for failure of virus envelopment as a cause of abortive infection, J Virol, vol.2, pp.384-92, 1968.

W. W. Rodrigo, J. X. Blackley, S. D. Rose, R. C. Schlesinger, and J. J. , Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcc RIA (CD64) or FccRIIA (CD32), J Virol, vol.80, pp.10128-10166, 2006.

M. V. Lukens, D. Kruijsen, F. Coenjaerts, J. Kimpen, and G. M. Van-bleek, Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung-draining lymph node, J Virol, vol.83, pp.7235-7278, 2009.

D. S. Mcdermott, K. A. Weiss, C. J. Knudson, and S. M. Varga, Central role of dendritic cells in shaping the adaptive immune response during respiratory syncytial virus infection, Future Virol, vol.6, pp.963-73, 2011.

T. S. Kim and T. J. Braciale, Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8

+. , PLoS ONE, vol.4, p.4204, 2009.

K. Y. Vermaelen, I. Carro-muino, B. N. Lambrecht, and R. A. Pauwels, Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes, J Exp Med, vol.193, pp.51-60, 2001.

H. S. Bandukwala, B. S. Clay, J. Tong, P. D. Mody, J. L. Cannon et al., Signaling through Fcc RIII is required for optimal T helper type (Th)2 responses and Th2-mediated airway inflammation, J Exp Med, vol.204, pp.1875-89, 2007.

T. Watanabe, M. Okano, H. Hattori, T. Yoshino, N. Ohno et al., Roles of FccRIIB in nasal eosinophilia and IgE production in murine allergic rhinitis, Am J Respir Crit Care Med, vol.169, pp.105-117, 2004.

A. Bukreyev, L. Yang, J. Fricke, L. Cheng, J. M. Ward et al., The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes, J Virol, vol.82, pp.12191-204, 2008.

E. Sunay, M. M. Fox-talbot, K. Velidedeoglu, E. Baldwin, W. M. Wasowska et al., Absence of FccRIII results in increased proinflammatory response in FccRIII-KO cardiac recipients, Transplantation, vol.96, pp.601-609, 2013.

J. S. Tregoning, B. L. Wang, J. U. Mcdonald, Y. Yamaguchi, J. A. Harker et al., Neonatal antibody responses are attenuated by interferon-c produced by NK and T cells during RSV infection, Proc Natl Acad Sci, vol.110, pp.5576-81, 2013.

L. Tasker, R. Lindsay, B. T. Clarke, D. Cochrane, and S. Hou, Infection of mice with respiratory syncytial virus during neonatal life primes for enhanced antibody and T cell responses on secondary challenge, Clin Exp Immunol, vol.153, pp.277-88, 2008.

J. S. Tregoning, Y. Yamaguchi, J. Harker, B. Wang, and P. Openshaw, The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice, J Virol, vol.82, pp.4115-4139, 2008.

Y. Hamano, H. Arase, H. Saisho, and T. Saito, Immune complex and Fc receptor-mediated augmentation of antigen presentation for in vivo Th cell responses, J Immunol, vol.164, pp.6113-6122, 2000.

H. E. Nielsen, V. Siersma, S. Andersen, B. Gahrn-hansen, C. H. Mordhorst et al., Respiratory syncytial virus infection-risk factors for hospital admission: a case-control study, Acta Paediatr, vol.92, pp.1314-1335, 2003.

A. Eick, R. Karron, J. Shaw, B. Thumar, R. Reid et al., The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease, Pediatr Infect Dis J, vol.27, pp.207-219, 2008.

R. H. Parrott, H. W. Kim, J. O. Arrobio, D. S. Hodes, B. R. Murphy et al., II. infection and disease with respect to age, immunologic status, race and sex, Am J Epidemiol, vol.98, pp.289-300, 1973.

L. R. Bulkow, R. J. Singleton, R. A. Karron, and L. H. Harrison, Risk factors for severe respiratory syncytial virus infection among Alaska native children, Pediatrics, vol.109, pp.210-216, 2002.

L. G. Stensballe, H. Ravn, K. Kristensen, K. Agerskov, T. Meakins et al., Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze, J Allergy Clin Immunol, vol.123, pp.398-403, 2009.